Drugs Worth Rs 4.87L Of ESI Hospital Supply Found In A Raid

Hyderabad:  The Telangana Drugs Control Administration (DCA), Karimnagar Zone, raided Srinivasa Medical and General Stores, located in Osmanpura, Karimnagar, and discovered drugs supplied for ESI hospital illegally stocked for sale.

During the raid, five types of drugs labelled ‘ESI SUPPLY NOT FOR SALE’ were seized, with the stock valued at Rs 4.87 lakh. The seized medications included antidiabetic and antiasthmatic drugs, among others.

DG DCA, V Kamalasan Reddy, reported that Dunaboina Murali Rao, a pharmacist grade-II at the ESI dispensary in SPM Colony, Sirpur-Kagaznagar, Kumuram Bheem Asifabad district, had illegally diverted ESI hospital supplies to managing partner of Sri Srinivasa Medical and General Stores, Gampa Krishna, in Karimnagar.

The raid was conducted by the assistant director, Karimnagar, M Srinivasulu, alongside drugs inspectors P Karthik Bharadwaj, T Chandana and P Shravan Kumar, from Karimnagar, Mancherial and Peddapalli.

DCA officers have taken samples for analysis, and further investigation is underway. Legal action will be taken against all offenders in accordance with the law.

Government pharmacists found guilty of illegally diverting hospital supplies are punishable under the Drugs and Cosmetics Act (DCA), with stringent measures promised against such individuals.

Officials warned that the illegal stocking of ESI hospital supply drugs for sale is punishable under the Drugs and Cosmetics Act, with imprisonment of up to two years.

Related Posts

AB-PMJAY Crackdown: 2,359 Hospitals De-empanelled, 1,200 Suspended for Violating Scheme Guidelines, Nadda Tells Lok Sabha

New Delhi: The Centre has disclosed a significant enforcement action against hospitals found violating the guidelines of the Ayushman Bharat–Pradhan Mantri Jan Arogya Yojana (AB-PMJAY), with 2,359 hospitals de-empanelled, 1,200…

NHS backs delayed‑release treatment for cystinosis

Decision expands options for eligible patients NHS England has recommended delayed‑release mercaptamine bitartrate for routine commissioning for eligible patients aged one year and above with nephropathic cystinosis. The decision provides…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

AB-PMJAY Crackdown: 2,359 Hospitals De-empanelled, 1,200 Suspended for Violating Scheme Guidelines, Nadda Tells Lok Sabha

AB-PMJAY Crackdown: 2,359 Hospitals De-empanelled, 1,200 Suspended for Violating Scheme Guidelines, Nadda Tells Lok Sabha

NHS backs delayed‑release treatment for cystinosis

NHS backs delayed‑release treatment for cystinosis

Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

Telangana DCA Seizes Gabapentin Tablets Falsely Sold as Nutraceuticals in Hyderabad

Telangana DCA Seizes Gabapentin Tablets Falsely Sold as Nutraceuticals in Hyderabad

Massive Blood Wastage in Gujarat: Over 85,000 Units Discarded Due to Storage Lapses and Expiry

Massive Blood Wastage in Gujarat: Over 85,000 Units Discarded Due to Storage Lapses and Expiry